Plant extracts for the treatment of increased bone resorption

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/04 (2006.01) A61K 38/05 (2006.01)

Patent

CA 2546180

The present invention concerns the use of .gamma.-glutamyl-peptide, for example .gamma. -L- glutamyltrans-S-1-propenyl-L-cysteine sulfoxide, in the treatment or prevention of diseases or conditions which are characterized by increased bone resorption, such as Paget's disease, tumor-induced bone disease or osteoporosis, inhibits dose-dependently the resorption activity of osteoclasts, the minimal effective dose being about 2 mM.

L'invention concerne l'utilisation d'un .gamma.-glutamyl-peptide, par exemple .gamma.-L-glutamyl-trans-S-1-propényl-L-cystéine sulfoxyde, afin de traiter ou de prévenir des maladies ou des états caractérisés par une augmentation de la résorption osseuse, tels que la maladie de Paget, la maladie osseuse provoquée par une tumeur ou l'ostéoporose, ce qui consiste à inhiber sur une base de dosage l'activité de résorption des ostéoclastes, la dose minimale efficace étant d'environ 2 mM.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Plant extracts for the treatment of increased bone resorption does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Plant extracts for the treatment of increased bone resorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plant extracts for the treatment of increased bone resorption will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1558876

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.